Jacobs and Company »

Regeneron Pharmaceuticals shares owned by Jacobs and Company

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Jacobs and Company from 13F filings

Historical chart of Jacobs and Company investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Jacobs and Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Jacobs and Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.1M 9.5k 962.43
2023-12-31 $8.4M 9.5k 878.27
2023-09-30 $8.0M 9.7k 822.87
2023-06-30 $7.2M 10k 718.45
2023-03-31 $8.4M 10k 821.61
2022-12-31 $8.1M 11k 721.46
2022-09-30 $8.0M 12k 688.84
2022-06-30 $6.8M 12k 591.07
2022-03-31 $8.6M 12k 698.39
2021-12-31 $8.0M 13k 631.44
2021-09-30 $7.5M 12k 605.15
2021-06-30 $6.8M 12k 558.54
2021-03-31 $5.7M 12k 473.12
2020-12-31 $5.2M 11k 483.05
2020-09-30 $5.1M 9.1k 559.73
2020-06-30 $3.0M 4.8k 623.65
2020-03-31 $2.9M 6.0k 488.26
2017-12-31 $996k 32k 31.56
2017-09-30 $1.1M 36k 31.98
2017-06-30 $1.2M 38k 31.80
2017-03-31 $1.2M 38k 32.01
2016-12-31 $1.5M 52k 28.52
2016-09-30 $345k 859 401.63